The efficacy of PD-L1 blockade on PD-L1 negative medulloblastoma is dependent on timing and the tumor microenvironment

被引：0
|
作者：
Allen, Frederick [1 ,2 ]
Dorand, Rodney Dixon [1 ]
Rauhe, Peter [1 ,2 ]
Petrosiute, Agne [1 ,2 ,3 ]
Huang, Alex Y. [2 ,4 ,5 ]
机构：
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
[2] Univ Hosp, Dept Pediat, Cleveland, OH USA
[3] Rainbow Babies & Childrens Hosp, Univ Hosp, 2101 Adelbert Rd, Cleveland, OH 44106 USA
[4] Angie Fowler AYA Canc Inst, Cleveland, OH USA
[5] Case Comprehens Canc, Cleveland, OH USA
来源：
JOURNAL OF IMMUNOLOGY | 2018年 / 200卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
178.14
引用
收藏
页数：3
相关论文
共 50 条
  • [31] PD-1/PD-L1 Blockade Enhances the Efficacy of Imatinib in Gastrointestinal Stromal Tumor (GIST)
    Seifert, Adrian M.
    Kim, Teresa S.
    Greer, Jonathan B.
    Cohen, Noah A.
    Beckman, Michael J.
    Santamaria-Barria, Juan A.
    Zeng, Shan
    Crawley, Megan H.
    Green, Benjamin L.
    DeMatteo, Ronald P.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (03) : S129 - S129
  • [32] The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade
    Li, Howard Y.
    McSharry, Maria
    Bullock, Bonnie
    Nguyen, Teresa T.
    Kwak, Jeff
    Poczobutt, Joanna M.
    Sippel, Trisha R.
    Heasley, Lynn E.
    Weiser-Evans, Mary C.
    Clambey, Eric T.
    Nemenoff, Raphael A.
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (09) : 767 - 777
  • [33] Cimetidine enhances PD-1 blockade efficacy in melanoma by regulating PD-L1 expression on tumor
    Lee, B.
    Kim, D.
    Lee, B.
    Lee, J.
    Shin, K.
    Kim, H.
    Ko, H.
    Kim, B.
    Kim, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S217 - S217
  • [34] Toxicities Associated With PD-1/PD-L1 Blockade
    Wang, Daniel Y.
    Johnson, Douglas B.
    Davis, Elizabeth J.
    CANCER JOURNAL, 2018, 24 (01): : 36 - 40
  • [35] PD-1 and PD-L1 blockade in gastrointestinal malignancies
    Lote, Hazel
    Cafferkey, Catherine
    Chau, Ian
    CANCER TREATMENT REVIEWS, 2015, 41 (10) : 893 - 903
  • [36] Mechanisms of Resistance to PD-1 and PD-L1 Blockade
    Nowicki, Theodore S.
    Hu-Lieskovan, Siwen
    Ribas, Antoni
    CANCER JOURNAL, 2018, 24 (01): : 47 - 53
  • [37] PD-L1 blockade for urothelial carcinoma
    Kang, Josephine
    Galluzzi, Lorenzo
    ONCOIMMUNOLOGY, 2017, 6 (07):
  • [38] Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
    Xianjie Jiang
    Jie Wang
    Xiangying Deng
    Fang Xiong
    Junshang Ge
    Bo Xiang
    Xu Wu
    Jian Ma
    Ming Zhou
    Xiaoling Li
    Yong Li
    Guiyuan Li
    Wei Xiong
    Can Guo
    Zhaoyang Zeng
    Molecular Cancer, 18
  • [39] From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades
    Zhao, Xuan
    Bao, Yulin
    Meng, Bi
    Xu, Zijian
    Li, Sijin
    Wang, Xu
    Hou, Rui
    Ma, Wen
    Liu, Dan
    Zheng, Junnian
    Shi, Ming
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [40] PD-1/PD-L1 axis importance and tumor microenvironment immune cells
    Lotfinejad, Parisa
    Kazemi, Tohid
    Mokhtarzadeh, Ahad
    Shanehbandi, Dariush
    Niaragh, Farhad Jadidi
    Safaei, Sahar
    Asadi, Milad
    Baradaran, Behzad
    LIFE SCIENCES, 2020, 259
12345